AT-004
Acne Vulgaris (AV)
Phase IIaActive
Key Facts
About Arctic Therapeutics
Arctic Therapeutics is a European biotech utilizing Iceland's extensive genetic and genealogical database to identify novel drug targets and develop small molecule therapies. The company is currently in clinical stages, with its lead program, AT-004 for acne vulgaris, having entered a Phase IIa trial. Its core strategy involves translating population-scale genetic insights into treatments for neurology, autoimmune, and inflammatory conditions, supported by a network of international scientific collaborators.
View full company profile